Annexon (ANNX) Free Cash Flow (2019 - 2026)
Annexon's (ANNX) quarterly Free Cash Flow came in at -$46.5 million in Q1 2026, up 7.2% year-on-year from -$43.4 million in Q1 2025, and up 8.96% quarter-over-quarter from -$51.1 million in Q4 2025.
Annexon (ANNX) Free Cash Flow (2019 - 2026) Analysis & Trends
Annexon's Free Cash Flow history runs 8 years deep, the most recent figure standing at -$46.5 million for Q1 2026.
- On a quarterly basis, Free Cash Flow rose 7.2% year-over-year to -$46.5 million in Q1 2026; TTM through Mar 2026 was -$188.1 million, a 34.45% decrease from a year earlier, with the FY2025 full-year figure at -$191.7 million, down 62.4% from the prior year.
- Free Cash Flow climbed to -$46.5 million in Q1 2026 per ANNX's latest filing, from -$51.1 million in the prior quarter.
- Across five years, Free Cash Flow topped out at -$21.7 million in Q2 2024 and bottomed at -$52.4 million in Q3 2025.
- The 5-year median for Free Cash Flow is -$33.0 million (2023), against an average of -$35.0 million.
- Across the five-year window, Free Cash Flow jumped 40.59% in 2024 and slumped 75.44% in 2025, its largest moves.
- Year by year, Free Cash Flow stood at -$27.1 million in 2022, then increased by 13.44% to -$23.5 million in 2023, then tumbled by 53.39% to -$36.0 million in 2024, then sank by 41.86% to -$51.1 million in 2025, then climbed by 8.96% to -$46.5 million in 2026.
- Per Business Quant, the three latest ANNX Free Cash Flow figures stand at -$46.5 million (Q1 2026), -$51.1 million (Q4 2025), and -$52.4 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.58 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 158.09 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.29 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 848.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.95 Mn |
| 10 | Annexon | 1.03 Bn | 804.24 Mn | - | -46.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -46.52 Mn |
| Mar 31, 2026 | -46.52 Mn |
| Dec 31, 2025 | -51.10 Mn |
| Dec 31, 2025 | -51.10 Mn |
| Sep 30, 2025 | -52.35 Mn |
| Sep 30, 2025 | -52.35 Mn |
| Jun 30, 2025 | -38.09 Mn |
| Jun 30, 2025 | -38.09 Mn |
| Mar 31, 2025 | -50.13 Mn |
| Mar 31, 2025 | -50.13 Mn |
| Dec 31, 2024 | -36.02 Mn |
| Dec 31, 2024 | -36.02 Mn |
| Sep 30, 2024 | -32.02 Mn |
| Sep 30, 2024 | -32.02 Mn |
| Jun 30, 2024 | -21.71 Mn |
| Jun 30, 2024 | -21.71 Mn |
| Mar 31, 2024 | -28.63 Mn |
| Mar 31, 2024 | -28.63 Mn |
| Dec 31, 2023 | -23.48 Mn |
| Dec 31, 2023 | -23.48 Mn |